Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$57.75 -0.69 (-1.18%)
As of: Oct 2, 2026 · 1:41 PM EDT

Biomarin Pharmaceutical (BMRN) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Biomarin Pharmaceutical's Depreciation & Amortization (CF) came in at $97.64 million for Q2 2026, up 426.0% from $18.56 million a year earlier and up 495.0% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Biomarin Pharmaceutical reported Depreciation & Amortization (CF) of $152.97 million, up 83.8% year-over-year; for FY2025, it was $79.56 million, down 17.5% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of -5.4% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $96.43 million in FY2024 (-7.6%), $104.39 million in FY2023 (+2.4%), $101.97 million in FY2022 (-5.6%) and $108.04 million in FY2021 (+2.7%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2009.
  • Year-over-year, Depreciation & Amortization (CF) increased in 1 of the last eight quarters, with growth averaging 37.1%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2026 (growth of 426.0%), and the weakest in Q2 2025 (a decline of 29.9%).
  • Business Quant data shows BMRN's Depreciation & Amortization (CF) at $16.41 million (Q1 2026), $20.44 million (Q4 2025) and $18.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Biomarin Pharmaceutical 11.61 Bn 5.48 Bn 786.91 Mn 97.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 97.64 Mn
Mar 31, 2026 16.41 Mn
Dec 31, 2025 20.44 Mn
Sep 30, 2025 18.49 Mn
Jun 30, 2025 18.56 Mn
Mar 31, 2025 22.07 Mn
Dec 31, 2024 23.61 Mn
Sep 30, 2024 19.01 Mn
Jun 30, 2024 26.46 Mn
Mar 31, 2024 27.35 Mn
Dec 31, 2023 26.86 Mn
Sep 30, 2023 25.69 Mn
Jun 30, 2023 25.42 Mn
Mar 31, 2023 26.42 Mn
Dec 31, 2022 24.55 Mn
Sep 30, 2022 24.80 Mn
Jun 30, 2022 25.27 Mn
Mar 31, 2022 27.34 Mn
Dec 31, 2021 25.99 Mn
Sep 30, 2021 26.84 Mn
API Access

Biomarin Pharmaceutical Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BMRN&period=max&api_key=YOUR_API_KEY